FDA Adverse Event Injury Summary report: N

AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM - POSTERIOR

MDR report key: 2850571 · Received November 20, 2012

Report

Report Number
1018233-2012-01855
Event Type
Injury
Date Received
November 20, 2012
Report Date
January 9, 2017
Manufacturer
C.R. BARD, INC. (COVINGTON)
Product Code
FTL
PMA / PMN Number
K082571
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
ATTORNEY
Health Professional
N

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE REMAINS IMPLANTED. THE FINISHED PRODUCT MET ALL SPECIFICATIONS PRIOR TO BEING RELEASED FOR GENERAL DISTRIBUTION. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. THE INSTRUCTIONS FOR USE STATES IN THE ADVERSE REACTIONS: COMPLICATIONS ASSOCIATED WITH THE PROPER IMPLANTATION OF THE AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM MAY INCLUDE, BUT ARE NOT LIMITED TO THOSE TYPICALLY ASSOCIATED WITH SURGICALLY IMPLANTABLE MATERIALS, INCLUDING: POSTOPERATIVE HEMATOMA, SEROMA, ABSCESS OR FISTULA FORMATION, OR SCARRING WHICH MAY OCCUR FOLLOWING THE IMPLANT PROCEDURE. URINARY RETENTION, BLADDER OUTLET OBSTRUCTION AND OTHER VOIDING AND DEFECATORY DYSFUNCTIONS. THESE CONDITIONS MAY BE ASSOCIATED WITH OVER-CORRECTION/TOO MUCH TENSION PLACED ON THE IMPLANT. PERFORATIONS OR LACERATIONS OF VESSELS, NERVES, BLADDER, BOWEL, URETHRA, RECTUM, OR ANY VISCERA, WHICH MAY OCCUR DURING THE IMPLANTATION PROCEDURE. IRRITATION AT THE OPERATIVE WOUND SITE WHICH MAY ELICIT A FOREIGN BODY RESPONSE THAT LEADS TO WOUND DEHISCENCE, INFLAMMATION AND/OR INFECTION. EXTRUSION THROUGH VAGINAL EPITHELIUM OR EROSION INTO SURROUNDING VISCERA AND/OR MUCOSA. INFLAMMATION, SENSITIZATION, REJECTION OF BIOLOGIC MATERIALS, PAIN, DYSPAREUNIA, SCARIFICATION, CONTRACTION, DEVICE MIGRATION AND FAILURE OF THE PROCEDURE RESULTING IN RECURRENCE OF VAGINAL WALL PROLAPSE. URINARY INCONTINENCE (STRESS AND URGE). (B)(4).

Description of Event or Problem · 1

THE PATIENT'S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. ADDITIONAL INFORMATION HAS BEEN REQUESTED, BUT NOT YET RECEIVED. PER ADDITIONAL INFORMATION RECEIVED, THE PATIENT HAD SURGICAL REMOVAL OF THE MESH ON (B)(6) 2012. ASSOCIATED MDRS: 1018233-2012-01853 AND 1018233-2012-01854.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM - POSTERIOR FTL C.R. BARD, INC. (COVINGTON) NA UNK

Patients

Seq Age Sex Outcome Treatment
1 64 YR Female Required Intervention ALIGN URETHRAL SUPPORT SYSTEM| AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM-ANTERIOR| ALIGN URETHRAL SUPPORT SYSTEM| AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM-ANTERIOR